PRINCETON, N.J., Oct. 26, 2005 (PRIMEZONE) -- The Bull Market Report (http://www.bullmarket.com), a long-term growth and income-generating focused online investment newsletter, announced today that it has provided subscribers with a thorough look at the recent declines in Pentair (NYSE:PNR), Coventry Health Care (NYSE:CVH), and Lockheed Martin (NYSE:LMT) following their earnings reports, and examines the companies' prospects going forward. Earnings coverage on additional stocks can also be found in The Bull Market Report Archives and in upcoming issues.
All paid and trial subscribers to The Bull Market Report can now receive immediate access to The Bull Market Report's exclusive daily reports. As a trial or paid subscriber, you'll also gain access to our latest investment moves. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/?refer=BMR52
In its earnings coverage, The Bull Market Report looked at the following topics, among many others:
-- Are there any catalysts to propel Pentair's stock higher after
the company has lowered guidance two quarters in a row?
-- Have expectations gotten too high for Coventry Health Care
to deliver what investors want?
-- What positives does The Bull Market Report see in place that
will push Lockheed Martin's stock higher in the coming year?
About The Bull Market Report:
Launched in 1997, The Bull Market Report has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The Bull Market Report's Recommended List includes over 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. As a testament to the durability of its value-focused and fundamentally sound recommendations in both up and down markets, The Bull Market Report is one of the oldest continuously published investment newsletters online. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/?refer=BMR52
Subscribers also receive access to The Bull Market Report's special bonus reports, "Search Sector Outlook," "Biotech Sector Outlook," and "Understanding the Value of Insider Trading Data."
Note: This release was published by F.P. Real Ventures I, LLC (CRD #131926). Indie Research, LLC and the Bull Market editorial staff are not registered investment advisors, broker/dealers, or research analysts/organizations.